Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,089 | 3,150 | 2,379 | 3,812 | 1,195 |
| Operating Income | -3,089 | -3,150 | -2,379 | -3,812 | -1,195 |
| Interest Expense | 111 | 72 | 0 | 0 | 0 |
| Other Income | 80 | 1 | 7 | 34 | 63 |
| Pre-tax Income | -3,120 | -3,221 | -2,372 | -3,778 | -1,132 |
| Net Income Continuous | -3,120 | -3,221 | -2,372 | -3,778 | -1,132 |
| Net Income | $-3,120 | $-3,221 | $-2,372 | $-3,778 | $-1,132 |
| EPS Basic Total Ops | -3.97 | -5.61 | -4.32 | -7.00 | -2.10 |
| EPS Basic Continuous Ops | -3.96 | -5.61 | -4.34 | -7.00 | -2.10 |
| EPS Diluted Total Ops | -3.97 | -5.61 | -4.32 | -7.00 | -2.10 |
| EPS Diluted Continuous Ops | -3.96 | -5.61 | -4.34 | -7.00 | -2.10 |
| EPS Diluted Before Non-Recurring Items | -3.97 | -5.61 | -4.32 | -7.02 | -2.10 |
| EBITDA(a) | $-3,006 | $-3,150 | $-2,379 | $-3,812 | $-1,195 |